x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:11:31

Cambridge, UK based Alchemab Therapeutics last week...

BiotechTV - News ·

2025/05/15

CEO Jane Osbourn describes Alchemab's platform, which looks for people who are resilient to disease and then sequences them to understand why, and discusses this week's deal and the company's prior one with Lilly as well.

en-us

00:07:12

ASGCT 2025: The Co-Founder of ProQR discusses the...

BiotechTV - News ·

2025/05/15

ProQR Co-Founder & CSO Gerard Platenburg describes the company's RNA editing platform and the journey he has seen this field go through over time. Plus, updates on programs for cholestatic diseases, Rhett Syndrome, and MASH.

en-us

00:10:06

ASGCT 2025: Capsida Biotherapeutics is using its...

BiotechTV - News ·

2025/05/14

CEO Peter Anastasiou describes the importance of capsid design and how Caspida is developing its own gene therapies for CNS conditions. A first program recently had its IND cleared.

en-us

00:09:27

ASGCT 2025: The co-founders of Circio describe the...

BiotechTV - News ·

2025/05/14

CEO Erik Wiklund and CTO Thomas Hansen describe what circular RNA is, and explain their groundbreaking work where they discovered circular RNA in humans over a decade ago. They discuss potential use cases, including using it for in-vivo CAR-T, something that has been talked about a lot at this year's conference.

en-us

00:12:30

Gene therapies expert TJ Cradick previews what to...

BiotechTV - News ·

2025/05/13

He discusses the clinical programs, delivery vehicle advances, and safety improvements to watch for this year as the field of cell and gene therapies progresses.

en-us

00:17:00

Inductive Bio raised a $25M series A last week to...

BiotechTV - News ·

2025/05/13

Inductive Bio raised a $25M series A last week to continue its work utilizing AI to help drug developers in discovery understand a small molecule's ADMET properties before it is synthesized.

en-us

00:19:34

NewLimit raised a $130M series B round last week to...

BiotechTV - News ·

2025/05/12

Co-Founder & President Jacob Kimmel and Head of Operations Cathy O'Hare describe the scientific approach and how it benefits from the crossroads of genomics and machine learning. Plus, which indications the company plans to start out in clinically.

en-us

00:19:03

Biotech investor Christoph Broja of EQT Life Sciences...

BiotechTV - News ·

2025/05/09

He describes the current environment for life sciences in Europe and how far it has come over the last ten years. Plus, his thoughts on the value of being local for uncovering opportunities, and the state of the capital markets.

en-us

00:13:18

With a phase 3 trial for its PRAME cell therapy...

BiotechTV - News ·

2025/05/09

CEO Harpreet Singh joins us from the company's office in Munich, Germany, where he describes the founding of the company and previews catalysts to watch for over the year ahead.

en-us

00:06:59

Mosaic Therapeutics, which uses advanced...

BiotechTV - News ·

2025/05/09

Interim CEO Magda Jonikas describes Mosaic's platform and the rationale behind these two targets the company has licensed in.

en-us

00:09:44

Cambridge, UK based Epitopia is helping Merck (MSD)...

BiotechTV - News ·

2025/05/09

CEO Alan Rigby talks about the work Epitopia does finding "Crypotgen" antigens for its own off-the-shelf cancer vaccines, and discusses what was appealing to Merck about the partnership.

en-us

00:16:49

Munich based Tubulis is working on ADCs that it...

BiotechTV - News ·

2025/05/08

Co-Founder and CEO Dominik Schumacher describes what he thinks can be improved on from the current generation of antibody-drug conjugates, and the science behind how Tubilis is designing its ADCs differently. He highlights the company's clinical Napi2b and 5T4 programs.

en-us

00:19:33

As the field builds on the initial success of PARP...

BiotechTV - News ·

2025/05/08

CEO Niall Martin walks us through the current state of this corner of drug development, and then highlights data presented at AACR last week for its ATR kinase inhibitor. As he describes, patient selection for these therapies can make a big difference.

en-us

00:20:34

Munich based ITM Radiopharma is progressing towards a...

BiotechTV - News ·

2025/05/08

CEO Andrew Cavey describes how ITM has been investing to avoid the shortages others have experienced, and explains how the supply chain works for radiopharmaceuticals. He walks us through the science behind these medicines before highlighting ITM's pipeline.

en-us

00:15:43

Munich based Ethris is developing a proprietary mRNA...

BiotechTV - News ·

2025/05/07

CEO Carsten Rudolph and CMO Thomas Langenickel describe the technology, which can be spray dried and shipped in a dry powder formulation, and also the clinical experience so far on the lead program in asthma.

en-us

00:07:45

Swiss Biotech Day: Geneva based Light Chain...

BiotechTV - News ·

2025/05/06

CEO Nicolas Fischer describes the rationale of designing bi-specifics this way, and walks us through the company's programs, which mostly have a CD47 or CD28 backbone.

en-us

00:08:56

Swiss Biotech Day: Milan based Genenta Science...

BiotechTV - News ·

2025/05/06

Co-Founder and CEO Pierluigi Paracchi describes the terms of the convertible bond raise, which gives the investor, ENEA Tech and Biomedical, the opporutnity to convert to equity in three years. He also provides an update on the progress of dosing renal cell carcinoma patients in the clinic, and what we can expect from the trial throughout the rest of the year.

en-us

00:09:38

Swiss Biotech Day: Lausanne based Tigen Pharma is...

BiotechTV - News ·

2025/05/06

Chairman & CEO Emmanuel Savioz describes the benefits of decentralized manufacturing that is at or near the site of treatment. He highlights an armored-CAR AML program the company has with MSK in New York, and discusses Tigen's non-viral platform for NHL and multiple myeloma.

en-us

00:10:29

Swiss Biotech Day: Lausanne based Vandria is focused...

BiotechTV - News ·

2025/05/06

CEO Klaus Dugi describes why the company is focused on mitochondria and how it using small molecules to fix them. He covers the three main disease areas Vandria is focused on, including a clinical program in mild cognitive impairment.

en-us

00:10:32

Swiss Biotech Day: Basel based BioVersys successfully...

BiotechTV - News ·

2025/05/06

Co-Founder & CEO Marc Gitzinger describes the success factors behind the IPO and walks us through the company's two lead programs. Plus, his thoughts on the evolving business model for this field.

en-us

432 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter